BridgeMD
New treatment option for Post-Stroke Cognitive Impairment (PSCI)
Official title Artificial Intelligence-Based Cognitive Training in Patients With Stroke
ClinicalTrials.gov ID: NCT07452276
What this study is testing
- What it's testing
- This study would answer the following question:Does AI application-based training improve cognitive function in Patients with Stroke? The aims of this study: To investigate the efficacy of AI application-based training on cognitive function in stroke patients.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 60
You may be able to join if
- Patient's age will range from 45- 60 years.
- Diagnosis of stroke in the chronic stage (≥3 months post-onset).
- Presence of cognitive impairment confirmed by a Montreal Cognitive Assessment (MoCA) score ≤ 26.
- Medically stable and able to follow instructions.
- patients with memory deficits following stroke
You likely can't join if
- \- Patients will be excluded if they have:
- Severe visual, hearing, or speech impairments prevent participation.
- History of other neurological or psychiatric disorders.
- Unstable cardiovascular or systemic disease.
- Severe depression (Beck Depression Inventory \> 29).
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Egypt, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 45 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Egypt, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.